Pender Ventures invests in B2B and health-tech companies with a thesis-driven, series-agnostic approach and a geographical focus on Canadian companies.
Pender Ventures invests in a concentrated selection of B2B and health-focused technology companies at their inflection point to scale, applying a scale-up framework and diversity influence aimed at driving top-quartile returns and creating tangible impact.
We focus on the stage of the company, rather than an arbitrary series, where we see:
Commercialized product(s) with early customer or partner revenue ($2-$5 million in revenue).
Clear understanding of the drivers of the business.
Capital efficient.
Well-defined path to liquidity.
We also focus on investing in companies that are:
Resilient
Need to have vs. nice to have technology.
Capital Efficient
Strong unit economics and a clear path to profitability.
High ROI Products
Products that increase revenue, decrease costs and/or improve outcomes.
